Metal Injection Moulding producer Thortex acquired by Avalign Technologies
July 31, 2017
Avalign Technologies, headquartered in Bannockburn, Illinois, USA, and a portfolio company of Arlington Capital Partners, has announced that it has completed the acquisition of Metal Injection Moulding producer Thortex.
Based in Portland, Oregon, USA, Thortex is a leading provider of proprietary porous coatings and Metal Injection Moulded components for the orthopaedic and aerospace markets, as well as precision manufacturing solutions for the medical device market. It is one of the only companies in the world that is able to provide porous coating solutions for titanium and cobalt-chrome orthopaedic implants.
Thortex provides a full suite of manufacturing and engineering technologies that, in addition to Metal Injection Moulding, include CNC machining, finishing and assembly to medical device OEMs.
Avalign Technologies also announced the acquisition of Millennium Surgical, Narberth, Pennsylvania, USA. Millennium is a provider of specialty surgical instruments which is focused on delivering difficult-to-find instruments through innovative e-cataloguing, web-based marketing and technical sales support.
The company offers more than 17,000 branded SKUs across a variety of clinical areas including neurosurgery, ophthalmics and orthopaedics to a diverse array of hospital and ambulatory surgical centre customers.
Matt Altman, a Managing Partner at Arlington Capital, stated, “The incorporation of Thortex and Millennium into the Avalign platform adds new and proprietary capabilities which enhance Avalign’s strategic position in the marketplace. The increased scale and breadth of services and technologies provided by these acquisitions will accrue to the benefit of Avalign’s customers and bolster Avalign’s already impressive growth.”
“Thortex and Millennium nicely complement and expand the manufacturing technologies and services that Avalign offers and provide us with the ability to continue gaining share with our customers,” stated Forrest Whittaker, CEO of Avalign Technologies.
“We are excited to welcome the Thortex and Millennium teams to the Avalign family, and thankful for Arlington’s support in consummating these highly strategic acquisitions.”
Malcolm Little, a Principal at Arlington Capital, added, “The proprietary technologies developed by both Thortex and Millennium represent truly unique offerings in the market. We are pleased to complete these acquisitions and continue to pursue additional opportunities to strategically scale our business.”